0

    530317

    GODAVARI

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    GODAVARI DRUGS LTD. Share Price Today

    Investment Returns

    Over 1 Month -0.76% Over 3 Months 33.11% Over 6 Months 62.79% Over 1 Year 35.62%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    GODAVARI DRUGS LTD. fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 122.50
    • P/E Ratio (TTM) 30.57
    • Beta 0.87
    • Book Value / share 69.65
    • Return on equity 10.64%
    • EPS (TTM) 3.75
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 1.29
    info icon alternate text

    GODAVARI DRUGS LTD. Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 33.16
    Operating Expense 31.80
    Net Profit 1.29
    Net Profit Margin (%) 3.89
    Earnings Per Share (EPS) 1.71
    EBITDA 3.19
    Effective Tax Rate (%) 20.37
    Particulars DEC 2025 (Values in Cr)
    Revenue 22.18
    Operating Expense 21.43
    Net Profit 0.76
    Net Profit Margin (%) 3.42
    Earnings Per Share (EPS) 1.01
    EBITDA 2.73
    Effective Tax Rate (%) 25.49
    Particulars SEP 2025 (Values in Cr)
    Revenue 26.65
    Operating Expense 26.17
    Net Profit 1.00
    Net Profit Margin (%) 3.75
    Earnings Per Share (EPS) 1.33
    EBITDA 2.63
    Effective Tax Rate (%) 10.71
    Particulars JUN 2025 (Values in Cr)
    Revenue 23.81
    Operating Expense 22.52
    Net Profit 1.04
    Net Profit Margin (%) 4.36
    Earnings Per Share (EPS) 1.38
    EBITDA 2.90
    Effective Tax Rate (%) 20.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 25.50
    Operating Expense 24.16
    Net Profit 0.89
    Net Profit Margin (%) 3.49
    Earnings Per Share (EPS) 1.19
    EBITDA 3.21
    Effective Tax Rate (%) 38.19
    Particulars MAR 2026 (Values in Cr)
    Revenue 105.81
    Operating Expense 101.91
    Net Profit 4.09
    Net Profit Margin (%) 3.86
    Earnings Per Share (EPS) 5.43
    EBITDA 11.46
    Effective Tax Rate (%) 19.16
    Particulars MAR 2025 (Values in Cr)
    Revenue 113.35
    Operating Expense 108.70
    Net Profit 4.38
    Net Profit Margin (%) 3.86
    Earnings Per Share (EPS) 5.82
    EBITDA 12.80
    Effective Tax Rate (%) 22.20
    Particulars MAR 2024 (Values in Cr)
    Revenue 156.71
    Operating Expense 150.32
    Net Profit 5.55
    Net Profit Margin (%) 3.54
    Earnings Per Share (EPS) 7.37
    EBITDA 13.83
    Effective Tax Rate (%) 19.79
    Particulars MAR 2023 (Values in Cr)
    Revenue 159.62
    Operating Expense 155.58
    Net Profit 3.79
    Net Profit Margin (%) 2.37
    Earnings Per Share (EPS) 5.03
    EBITDA 10.79
    Effective Tax Rate (%) 23.32
    Particulars MAR 2022 (Values in Cr)
    Revenue 161.11
    Operating Expense 154.35
    Net Profit 5.25
    Net Profit Margin (%) 3.25
    Earnings Per Share (EPS) 6.97
    EBITDA 11.56
    Effective Tax Rate (%) 25.35
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 57.56
    ROE % 10.64
    ROCE % 10.06
    Total Debt to Total Equity 1.48
    EBITDA Margin 11.29
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 51.74
    ROE % 15.33
    ROCE % 14.14
    Total Debt to Total Equity 1.29
    EBITDA Margin 8.83
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 44.38
    ROE % 12.02
    ROCE % 14.37
    Total Debt to Total Equity 0.93
    EBITDA Margin 6.77
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 39.35
    ROE % 19.44
    ROCE % 18.12
    Total Debt to Total Equity 0.99
    EBITDA Margin 7.18
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 32.38
    ROE % 18.50
    ROCE % 17.34
    Total Debt to Total Equity 1.30
    EBITDA Margin 8.36
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 2.37
    Total Assets 143.07
    Total Liabilities 143.07
    Total Equity 43.34
    Share Outstanding 0
    Price to Book Ratio 1.52
    Return on Assets (%) 3.06
    Return on Capital (%) 4.17
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 2.62
    Total Assets 134.75
    Total Liabilities 134.75
    Total Equity 38.96
    Share Outstanding 0
    Price to Book Ratio 1.80
    Return on Assets (%) 4.11
    Return on Capital (%) 5.87
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 3.08
    Total Assets 121.43
    Total Liabilities 121.43
    Total Equity 33.41
    Share Outstanding 0
    Price to Book Ratio 1.71
    Return on Assets (%) 3.11
    Return on Capital (%) 5.66
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 2.27
    Total Assets 101.41
    Total Liabilities 101.41
    Total Equity 29.63
    Share Outstanding 0
    Price to Book Ratio 1.66
    Return on Assets (%) 5.17
    Return on Capital (%) 10.5
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 1.63
    Total Assets 91.13
    Total Liabilities 91.13
    Total Equity 24.38
    Share Outstanding 0
    Price to Book Ratio 1.41
    Return on Assets (%) 4.52
    Return on Capital (%) 7.87
    Particulars MAR 2025 (Values in Cr)
    Net Income 12.80
    Cash from Operations 12.35
    Cash from Investing -19.51
    Cash from Financing 8.06
    Net change in Cash -0.24
    Free Cash Flow 32.34
    Particulars MAR 2024 (Values in Cr)
    Net Income 13.83
    Cash from Operations 19.43
    Cash from Investing -13.22
    Cash from Financing -5.65
    Net change in Cash -0.46
    Free Cash Flow 32.63
    Particulars MAR 2023 (Values in Cr)
    Net Income 10.80
    Cash from Operations 14.36
    Cash from Investing -8.63
    Cash from Financing -3.77
    Net change in Cash 0.80
    Free Cash Flow 23.66
    Particulars MAR 2022 (Values in Cr)
    Net Income 11.56
    Cash from Operations 13.00
    Cash from Investing -4.97
    Cash from Financing -5.62
    Net change in Cash 0.63
    Free Cash Flow 18.25
    Particulars MAR 2021 (Values in Cr)
    Net Income 10.23
    Cash from Operations 2.90
    Cash from Investing -1.25
    Cash from Financing 0.13
    Net change in Cash 0.21
    Free Cash Flow 4.57
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.81 13.14 1.53 243.77 23.12 38.85
    BLISS GVS PHARMA LTD. 524.85 42.60 4.66 5566.36 118.35 552.90
    CIPLA LTD 1456.95 30.92 3.41 117699.02 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 354.50 15.64 2.56 1043.33 256.40 399.00
    GLAXOSMITHKLINE PHARMACEUTICAL 2463.40 43.37 18.40 41731.48 2088.00 3450.05
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.81 22.24 4.09 243.77 23.12 38.85
    AMRUTAJAN HEALTH LTD 549.45 24.63 4.29 1588.49 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8216.55 107.31 23.53 20541.38 7630.00 9850.00
    BLISS GVS PHARMA LTD. 524.85 56.62 4.81 5566.36 118.35 552.90

    GODAVARI DRUGS LTD. shareholding pattern

    Holding
    57.3%
    40.22%
    2.46%
    0.21%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    GODAVARI DRUGS LTD. Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    121.00 -2.02 redarrow
    red-green-graph indicator
    11 Bearish
    5 Bullish
    • 5 Days 121.60
    • 26 Days 122.20
    • 10 Days 121.80
    • 50 Days 118.80
    • 12 Days 121.90
    • 100 Days 110.30
    • 20 Days 122.30
    • 200 Days 102.20
    122.50 PIVOT
    First Support 121.50 First Resistance 124.50 Second Support 119.50 Second Resistance 125.50 Third Support 118.50 Third Resistance 127.50
    RSI 52.13 ADX 22.97 MACD -0.26 Williams % R -33.46 Commodity Channel Index (CCI) 3.26
    Date 2026-07-01 Week 3955.00 Same Day 1685.00 Month 3458.00
    1 Year 0.87 3 Year 0.63
    Over 1 Month
    -0.76% down
    Over 1 Year
    35.62% down
    Over 3 Months
    33.11% down
    Over 3 Years
    8.13% down
    Over 6 Months
    62.79% down
    Over 5 Years
    13.52% down

    GODAVARI DRUGS LTD. Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Godavari Drugs Ltd?

    Answer Field

    Godavari Drugs Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 121.00 as on Jul 02 2026 02:26 PM.

    What is the Market Cap of Godavari Drugs Ltd Share?

    Answer Field

    The market cap of Godavari Drugs Ltd for NSE ₹ 0.00 & for BSE ₹ 122.50 as on Jul 02 2026 02:26 PM.

    What is the 52 Week High and Low of Godavari Drugs Ltd?

    Answer Field

    The 52 Week High and Low of Godavari Drugs Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 135.25 and ₹ 69.70.

    What is 1 year return for Godavari Drugs Ltd?

    Answer Field

    The 1 year returns on the stock has been 35.62%.

    What is the P/E Ratio of Godavari Drugs Ltd Share?

    Answer Field

    As on Jul 02 2026 02:26 PM the price-to-earnings (PE) ratio for Godavari Drugs Ltd share is 30.57.

    What is the PB ratio of Godavari Drugs Ltd Share?

    Answer Field

    As on Jul 02 2026 02:26 PM, the price-to-book (PB) ratio for Godavari Drugs Ltd share is 69.65.

    How to Buy Godavari Drugs Ltd Share?

    Answer Field

    You can trade in Godavari Drugs Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Godavari Drugs Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Godavari Drugs Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Godavari Drugs Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |